Stockreport

PMV Pharmaceuticals GAAP EPS of -$0.37 misses by $0.02 [Seeking Alpha]

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF Cash, cash equivalents, and marketable securities of $197.9 million as of September 30, 2024, providing expected cash runway to end of 2026. More on PMV Pharmaceutica [Read more]